Weiss Amir 4
4 · TEVA PHARMACEUTICAL INDUSTRIES LTD · Filed Mar 6, 2025
Insider Transaction Report
Form 4
Weiss Amir
Chief Accounting Officer
Transactions
- Exercise/Conversion
Ordinary Shares
2025-03-04+10,676→ 21,034 total - Exercise/Conversion
Ordinary Shares
2025-03-04+5,650→ 26,684 total - Exercise/Conversion
Restricted Share Units
2025-03-04−10,676→ 10,679 total→ Ordinary Shares (10,676 underlying) - Exercise/Conversion
Restricted Share Units
2025-03-04−5,650→ 16,950 total→ Ordinary Shares (5,650 underlying)
Footnotes (4)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F3]Restricted share units were granted on March 4, 2022, with 10,676 vested on each of March 4, 2023, March 4, 2024 and March 4, 2025, and 10,679 vesting on March 4, 2027.
- [F4]Restricted share units were granted on March 4, 2024, with 5,650 vested on March 4, 2025, and 5,650 vesting on each of March 4, 2026, March 4, 2027 and March 4, 2028.